Cargando…

A Phase 2 Evaluation of a Novel Co-Formulation of Pramlintide and Regular Insulin to Improve Postprandial Glycemic Control in Adults with Type 1 Diabetes (T1D)

Objective: Pramlintide co-administration, used in conjunction with prandial insulin, has substantial clinical benefits to improve post-prandial glucose excursions, glycemic variability (GV) and time in range (TIR), but is associated with an increased injection burden that adversely affects adherence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edelman, Steven Victor, Conoscenti, Valentina, Junaidi, M Khaled, Close, Nicole, Sequeira, David, Nguyen, Anh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265936/ http://dx.doi.org/10.1210/jendso/bvab048.669

Ejemplares similares

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

MON-LB115 Ready-To-Use Glucagon for the Prevention of Exercise-Induced Hypoglycemia in a Clinical Research Setting
por: Aronson, Ronnie, et al.
Publicado: (2020)

MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure
por: Pettus, Jeremy H, et al.
Publicado: (2020)

Reconsidering the Basal Proportion of Insulin Dose: Glycemic and Microvascular Outcomes in Type 1 Diabetes Mellitus
por: Pozos-Varela, Francisco Javier, et al.
Publicado: (2021)

OR22-5 Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption
por: Powell, David, et al.
Publicado: (2019)

MON-152 Less Is More: Human Regular U-500 Insulin
por: Lugo Lopez, Zahira, et al.
Publicado: (2019)

SUN-151 Improved Glycemic Control with Automated Insulin Pump (AIP) Technology
por: Amole, Morolake, et al.
Publicado: (2019)

SAT-145 Insulin Technique Assessment and Its Association with Glycemic Control amongst Inpatients with Diabetes
por: Gulati, Neha, et al.
Publicado: (2019)

Continuous Subcutaneous Insulin Infusion Therapy Resulting in Improved Glycemic Control in Patient With Low Health Literacy
por: Mandal, Shobha, et al.
Publicado: (2021)

OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry
por: Wysham, Carol, et al.
Publicado: (2019)

SUN-133 Glycemic Control in T1D Subjects before and after Pancreas Transplantation
por: Dadlani, Vikash, et al.
Publicado: (2019)

OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
por: Mora, Pablo, et al.
Publicado: (2020)

MON-663 Prandial Insulin Dosing Based on Carbohydrate Content Does Not Significantly Improve Glycemic Control in Hospitalized Patients with Diabetes
por: Goel, Heenam, et al.
Publicado: (2020)

An Analysis of Medtronic Minimed 670g Insulin Pump Use in Clinical Practice and the Impact on Glycemic Control, Quality of Life, and Compliance
por: Horowitz, Maxwell E, et al.
Publicado: (2021)

OR14-1 Pharmacodynamics, Safety, Tolerability, and Efficacy of Oral Insulin Formulation (Oshadi Icp) among Young Adults with Type 1 Diabetes: A Summary of Clinical Studies Phases I, Ib, and Ii
por: Rachmiel, Marianna, et al.
Publicado: (2019)

MON-653 The Effects of DPP IV Inhibitor on Glycemic Variability in Type 2 Diabetic Patients Treated with Twice Daily Premixed Human Insulin
por: Tan, Florence Hui Sieng, et al.
Publicado: (2020)

SUN-140 The Ways of Achievement the Target Levels of Glycemic Control in Children and Adolescents with Type 1 Diabetes
por: Muz, Nataliia, et al.
Publicado: (2019)

Association Between Serum Magnesium and Glycemic Control, Lipid Profile and Diabetic Retinopathy in Type 1 Diabetes
por: Inácio, Isabel, et al.
Publicado: (2021)

The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy
por: Bode, Bruce W, et al.
Publicado: (2021)

MON-130 Optimal Glycemic Control in a Patient with HNF1A MODY with GLP1-RA Monotherapy: Implications for Future Therapy
por: Fantasia, Kathryn, et al.
Publicado: (2019)

Impact of Covid19 Lockdown on Glycemic Control
por: Rodriguez, Giovanna, et al.
Publicado: (2021)

SUN-649 Metabolic and Functional Regulation of T Cells by Insulin and Insulin like Growth Factor 1
por: Kiernan, Kaitlin, et al.
Publicado: (2020)

MON-697 Necrotising Fasciitis- Importance of Glycemic Control
por: Kasireddy, Amulya Reddy, et al.
Publicado: (2020)

Improving Glycemic Control of Diabetic Patients in an Outpatient Practice
por: Gibbs, Otto T, et al.
Publicado: (2021)

MON-642 Genetic Knockout of Intestinal Hexokinase Domain-Containing Protein 1 Affects Whole-Body Glycemic Control and Triglyceride Metabolism
por: Zapater, Joseph Louis, et al.
Publicado: (2020)

Comparable Long-Term Glycemic Control and Insulin-Independent Rate at Less Cost By Using Intra-Operative vs. Islet Cell Laboratory Isolation for Total Pancreatectomy With Islet Auto-Transplantation
por: Chaidarun, Sushela S, et al.
Publicado: (2021)

OR30-01 Real-World Minimed™ 670G System Use and Glycemic Outcomes of Pediatric and Adult Individuals Living with Type 1 Diabetes (T1D) in the United States
por: Vigersky, Robert Alan, et al.
Publicado: (2020)

Time to Reach Glycemic Goal on an Outpatient Academic Endocrinology Clinic
por: Salinas, Leopoldo M Cobos, et al.
Publicado: (2021)

In-Hospital Glycemic Dysregulation Associated With Worse Outcomes in COVID-19
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

MON-173 Vitamin D And Glycemic Control In Type 2 Diabetes
por: Jadoon, Nauman, et al.
Publicado: (2019)

Glycemic Control & Morbidity in Diabetics With COPD Exacerbation. A Retrospective Study
por: Naoum, Ibrahim, et al.
Publicado: (2021)

OR08-02 Do OGTT-based Insulin Secretory Response Measures Approximate 1(st) Phase Insulin Response in Pregnant Women?
por: Powe, Camille Elise, et al.
Publicado: (2020)

SAT-648 Flash Glucose Monitoring Helps Achieve Better Glycemic Control Than Conventional Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes: A Randomized Controlled Trial
por: Wada, Eri, et al.
Publicado: (2020)

SAT-136 Investigation of Glycemic State among Responders to Hepatitis C Treatment
por: Elamir, Yasmine, et al.
Publicado: (2019)

MON-632 The Effects of a High Intensity Glycemic Program on Weight and BMI
por: Guzman, Heidi, et al.
Publicado: (2020)

Irisin Precursor FNDC5 and Glycemic Control in Patients With Type 2 Diabetes
por: Lima Mágero, Felipe Rodrigues, et al.
Publicado: (2021)

Young Adult LEW.1WR1 Rats Develop Dysregulated Islet Function and Impaired Liver Insulin Responses
por: Wilkerson-Vidal, Quiana C, et al.
Publicado: (2021)

SUN-696 Effect of Night Shifts on Glycemic Variability in Patients with Type 2 Diabetes
por: Garieva, Mayya Akakievna
Publicado: (2020)

SAT-637 Patient-Centered Glycemic Management of Type 2 Diabetes with Mobile Applications
por: Lau, Chap-Kay K, et al.
Publicado: (2020)

Effect of Glycemic Control on Outcome of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(AECOPD)
por: Guha, Abhraneel Parames
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ckap3017p1mhrkoaf4pafi7lbr